These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8582385)

  • 1. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure.
    Dutka DP; Olivotto I; Ward S; Nihoyannopoulos P; al-Subaili M; Oakley CM; Impallomeni M; Cleland JG
    Eur Heart J; 1995 Sep; 16(9):1223-30. PubMed ID: 8582385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
    van Kraaij DJ; Jansen RW; Sweep FC; Hoefnagels WH
    Eur J Heart Fail; 2003 Jan; 5(1):47-53. PubMed ID: 12559215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
    Missouris CG; Grouzmann E; Buckley MG; Barron J; MacGregor GA; Singer DR
    Clin Sci (Lond); 1998 Jun; 94(6):591-9. PubMed ID: 9854456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction.
    Dutka DP; Puri S; Strong R; Cleland JG
    Eur J Heart Fail; 1999 Dec; 1(4):371-7. PubMed ID: 10937950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
    Kjaer A; Hesse B
    Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction.
    Dutka DP; Olivotto I; Ward S; Oakley CM; Impallomeni M; Cleland JG
    Am J Cardiol; 1996 Jun; 77(14):1197-201. PubMed ID: 8651095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
    van den Berg MP; Tjeerdsma G; Jan de Kam P; Boomsma F; Crijns HJ; van Veldhuisen DJ
    Eur J Heart Fail; 2002 Jun; 4(3):255-62. PubMed ID: 12034149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
    Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure.
    Kato M; Kinugawa T; Omodani H; Osaki S; Ahmmed GU; Ogino K; Hisatome I; Miyakoda H; Thames MD
    J Card Fail; 1996 Jun; 2(2):103-10. PubMed ID: 8798111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
    Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
    Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
    Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
    Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
    Selçuk Y; San A; Bakan E; Yiğitoğlu R
    Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.